The decline in Q3 revenue is attributed to temporary factors such as US transplant volume headwinds and aircraft maintenance. Despite these challenges, TransMedics reiterated its long-term transplant volume target, suggesting confidence in future growth. The mention of international and organ-specific opportunities indicates potential areas for expansion, balancing the short-term negative impact with long-term optimism.